EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 299 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2018. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $15,000 | -21.1% | 299 | 0.0% | 0.00% | – |
| Q2 2021 | $19,000 | -45.7% | 299 | -19.0% | 0.00% | – |
| Q1 2021 | $35,000 | +29.6% | 369 | +23.4% | 0.00% | – |
| Q4 2020 | $27,000 | -12.9% | 299 | 0.0% | 0.00% | – |
| Q3 2020 | $31,000 | +29.2% | 299 | 0.0% | 0.00% | – |
| Q2 2020 | $24,000 | +1100.0% | 299 | +806.1% | 0.00% | – |
| Q1 2019 | $2,000 | -91.7% | 33 | -92.0% | 0.00% | – |
| Q4 2018 | $24,000 | +84.6% | 410 | -0.5% | 0.00% | – |
| Q3 2016 | $13,000 | +225.0% | 412 | +255.2% | 0.00% | – |
| Q1 2016 | $4,000 | -99.8% | 116 | -99.7% | 0.00% | -100.0% |
| Q4 2015 | $1,785,000 | +40.4% | 44,604 | 0.0% | 0.01% | +42.9% |
| Q3 2015 | $1,271,000 | +1296.7% | 44,604 | +837.8% | 0.01% | +600.0% |
| Q3 2013 | $91,000 | – | 4,756 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 1,810,519 | $52,071,000 | 4.06% |
| Avoro Capital Advisors LLC | 330,635 | $9,509,000 | 3.65% |
| FIDUCIARY MANAGEMENT ASSOCIATES LLC | 766,424 | $22,043,000 | 1.32% |
| GREAT POINT PARTNERS LLC | 102,791 | $2,956,000 | 1.30% |
| Matarin Capital Management, LLC | 75,380 | $2,167,929,000 | 0.66% |
| GLOBEFLEX CAPITAL L P | 89,151 | $2,564,000 | 0.49% |
| LaSalle Street Capital Management, LLC | 15,897 | $457,000 | 0.45% |
| TFS CAPITAL LLC | 149,318 | $4,294,000 | 0.42% |
| TURNER INVESTMENTS LLC | 71,880 | $2,067,000 | 0.37% |
| NEW AMSTERDAM PARTNERS LLC/NY | 136,116 | $3,915,000 | 0.32% |